周日版的纽约时报often includes a short feature in which a prominent person is asked to describe how he or she likes to spend an idle Sunday. Common activities are brunch, museums, outdoor activities, etc.
This came to mind yesterday as we watched more than 160 people gather for one of the final sessions of the fifty-second International Liver Congress (ILC). Whoever would have expected so many prominent people to pass on a leisurely Sunday morning in Amsterdam, after four long days of events, in favor of an 8.30 a.m. gathering titled “Elimination of hepatitis B and C in the EU: challenges and opportunities”?
该事件强调了直接作用抗病毒（DAA）治疗方案的巨大潜力，以降低PWID的HCV患病率和发病率，以及必须克服的程序，政治和结构性障碍，这些障碍必须被克服才能在实地上取得真正的进步。
本届会议仅代表了许多方式之一European Association for the Study of the Liver(EASL)有助于培养对公共的对话health dimensions of viral hepatitis at this year’s ILC. (Disclosure: the first author is a board member of EASL’s recently launched国际肝基金会。）
For us, one of the highlights of the conference was a 19 April workshop jointly convened by EASL and theInternational Network on Hepatitis in Substance Users（inhsu）。广泛的参与者讨论了从多个角度注射药物（PWID）的人中消除丙型肝炎病毒（HCV）的努力。该事件强调了直接作用抗病毒（DAA）治疗方案的巨大潜力，以降低PWID的HCV患病率和发病率，以及必须克服的程序，政治和结构性障碍，这些障碍必须被克服才能在实地上取得真正的进步。
这ILC程序还包括一个受人尊敬的世界卫生组织（WHO）关于“肝病学家作为实现WHO肝炎策略的消除目标的关键伴侣”研讨会。在题为“肝病学上的公共卫生问题”的一次抽象驱动的会议上，有宝贵的学习是从两个国家的HCV消除计划，佐治亚州和冰岛共享的，以及包括移民，监狱囚犯和PWID在内的关键人口的经验。
我们赞扬ILC的组织者认识到非生物医学专家不仅包括一系列卫生服务提供者和公共卫生从业人员，还包括肝脏患者。
Multidisciplinary approaches to liver disease were prominent at this ILC. We mean this both in the sense that the programme brought hepatologists and other types of physicians into dialogue about multidisciplinary clinical care, and also in the sense that it provided physicians and other experts with valuable opportunities to learn from each other.
It is exciting to see public health perspectives thoughtfully integrated into such a prestigious biomedical conference. And we applaud the ILC’s organisers for recognising that non-biomedical experts include not only a range of health service providers and public health practitioners but also liver patients.
来自肝脏患者群体的代表带来了我们其他人需要听到的观点。Tatjana Reic，，，，President of the欧洲肝脏患者协会，在欧盟HBV/HCV消除的周日早晨活动中恰当地证明了这一点。她在演讲中说，与其称PWID为“难以触及的人口”，为什么不称他们为“易于尊贵的”人群呢？
的确。
我们期待在EASL和ILC的未来版本中进一步交叉授粉。
肝病学，医学和政策现在正在接受有关此问题和相关问题的提交。有关更多信息，请访问：www.hmap.biomedcentral.com。
Comments